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Candida albicansBac8c (RIWVIWRR-NH2) is an analogue peptide derived through complete substitution analysis of the linear
bovine host defense peptide variant Bac2A. In the present study, the antifungal mechanism of Bac8c against
pathogenic fungi was investigated, with a particular focus on the effects of Bac8c on the cytoplasmic membrane.
We used bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] staining and 3,3’-dipropylthiacarbocyanine
iodide [DiSC3(5)] assays to show that Bac8c induced disturbances in the membrane potential of Candida albicans.
An increase in membrane permeability and suppression of cell wall regeneration were also observed in Bac8c-
treated C. albicans.We studied the effects of Bac8c treatment onmodelmembranes to elucidate its antifungalmech-
anism. Using calcein and FITC-labeled dextran leakage assays from Bac8c-treated large unilamellar vesicles (LUVs)
and giant unilamellar vesicles (GUVs), we found that Bac8c has a pore-forming action on fungal membranes, with
an estimatedpore radius of between2.3 and3.3nm.Amembrane-targetedmechanismof actionwas also supported
by the observation of potassium release from the cytosol of Bac8c-treated C. albicans. These results indicate
that Bac8c is considered as a potential candidate to develop a novel antimicrobial agent because of its low-cost
production characteristics and high antimicrobial activity via its ability to induce membrane perturbations in fungi.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Infectious diseases and antibiotic resistance are now considered
the most pressing global healthcare problems [1]. In the search for
new treatments, antimicrobial peptides have attracted considerable
attention due to their various unique properties [2]. Antimicrobial pep-
tides are important components of the innate immune defense against a
variety of microbial infections, and do not easily induce resistance com-
pared to conventional antibiotics [3]. However, a number of antimicro-
bial peptides are also cytotoxic to mammalian cells, which limits the
direct use of these peptides as therapeutics. In addition, native peptides
tend to be easily degraded and are expensive to produce [4]. As a result,
efforts are focused on modifying the native antimicrobial peptides or
designing new synthetic peptides to achieve better speciﬁcity against
microbial infections, fewer side-effects for the host organism, and a
minimal peptide length for inexpensive production [5]. A variety of
methods have been applied to design new antimicrobial peptides
based on the characteristics of the native peptides, such as replacing
some amino acid residues, changing the chirality of peptides, hybridiz-
ing different peptide segments to form new chimeric peptides, andtion; KCTC, Korean Collection
se; MIC, minimum inhibitory
ic acid) trimethine oxonol;
large unilamellar vesicle; PC,
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82 53 955 5522.de novo peptide designs [6–10]. Several studies have found that Bac8c,
a positively-charged (net charge +3) 8-mer peptide is modiﬁed from
Bac2A (RLARIVVIRVAR-NH2) [11]. The low-cost production and high
antimicrobial activity characteristics make Bac8c a potential candidate
for development into a novel antimicrobial drug in the clinical setting.
However, the effects of Bac8c on pathogenic fungi associatedwith infec-
tious disease remain largely unknown, limiting the clinical application
of Bac8c for the prevention and treatment of fungal infections. In this
study, we investigated the antimicrobial activity of Bac8c against path-
ogenic fungi, the inhibitory effect of Bac8c on Candida albicans, and
the mechanism of action of Bac8c on lipid membranes. We show that
Bac8c has the potential to be an alternative antifungal agent through
its actions on fungal cell membranes.
2. Materials and methods
2.1. Solid-phase peptide synthesis
The assembly of peptides consisted of a 60-min cycle for each
residue at ambient temperature as follows: (1) the 2-chlorotrityl
(or 4-methylbenzhydrylamine amide) resin was charged to a reac-
tor and then washed with dichloromethane (DCM) and N,N-
dimethylformamide (DMF), respectively, and (2) a coupling step
with vigorous shaking with a 0.14 mM solution of Fmoc-L-amino
acids and Fmoc-L-amino acids preactivated for approximately
60 min with a 0.1 mM solution of 0.5 M HOBt/DIC in DMF. Finally,
the peptide was cleaved from the resin with a triﬂuoroacetic acid
(TFA) cocktail solution at ambient temperature [12,13]. The purity
Table 2
Human erythrocyte lysis assay against Bac8c and melittin.
Peptides Hemolysis (%)
100.0 μM 50.0 μM 25.0 μM 12.5 μM 6.3 μM 3.1 μM 1.6 μM
Bac8c 0 0 0 0 0 0 0
Melittin 100 100 98.1 87.4 52.6 22.5 8.6
Table 1
The antifungal activity of Bac8c and melittin.
Fungal strains MIC (μM)
Bac8c Melittin
C. albicans ATCC 90028 6.3 1.6
C. parapsilosis ATCC 22019 12.5 3.1
M. furfur KCTC 7744 25.0 3.1–6.3
T. beigelii KCTC 7707 12.5 1.6–3.1
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tography (HPLC), and purity of synthesized peptide is greater than
95% (data not shown). The calculated molecular weight of Bac8c is
1183.46 Da, and observed molecular weight is 1183.50 Da.
2.2. Preparation of the fungal strains
C. albicans (ATCC 90028) and C. parapsilosis (ATCC 22019) were
obtained from the American Type Culture Collection (ATCC) (Manassas,
VA, USA). M. furfur (KCTC 7744) and T. beigelii (KCTC 7707) were
obtained from the Korean Collection for Type Cultures (KCTC) at
the Korea Research Institute of Bioscience and Biotechnology (KRIBB)
(Daejeon, Korea). The fungal strains were cultured in yeast extract
peptone dextrose (YPD) broth (BD Pharmigen, San Diego, CA, USA)
with aeration at 28 °C, and the M. furfur was cultured in a modiﬁed
yeast malt (YM) broth (BD Pharmigen) containing 1% olive oil at 32 °C.
2.3. Antifungal activity assay
Fungal cells (1 × 106 cells/mL) were inoculated into 0.1 mL wells
containing YPD or YM broth, and then dispensed to microtiter plates.
The minimum inhibitory concentrations (MICs) were determined
using a two-fold serial dilution of the test compounds, based on
the Clinical and Laboratory Standards Institute (CLSI) method [14],
with the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) assay used to evaluate fungal cell viability [15]. After
48 h of incubation, the minimal concentration of the test peptides re-
quired to prevent the growth of the microorganisms was determined,
and was deﬁned as the MIC. Cell growth was measured by optical
density at 580 nm with a microtiter ELISA Reader (Molecular Devices
Emax; Sunnyvale, CA, USA). The MIC values were determined by three
independent assays.
2.4. Hemolytic activity assay
A fresh human blood sample was diluted in PBS (pH 7.4) and centri-
fuged at 300 ×g for 10 min to remove the plasma and buffy coat, and
the supernatant was removed. This washing procedure was repeated
three times, and the ﬁnal concentration of the erythrocytes was 8%.
The erythrocyte suspension was transferred into 96-well plates and
incubated with peptides at 37 °C for 1 h. The plate was centrifuged at
180 ×g for 10 min. An aliquot of the supernatant was taken, and then
the hemolysis was evaluated by determining the release of hemoglobin
from the 8% suspension of human erythrocytes at 414 nmwith an ELISA
reader. Zero and 100% hemolysis were determined in PBS alone and
with 0.1% Triton X-100, respectively. The hemolysis percentage was
calculated using the following equation: Hemolysis (%) = [(Abs414nm
in the peptide solution – Abs414nm in PBS)/(Abs414nm in 0.1% Triton
X-100 – Abs414nm in PBS)] × 100 [16]. Results are based on three
independent experiments, performed in triplicate.
2.5. Cell wall regeneration of protoplast
For the protoplast preparation of C. albicans, cells (1 × 106 cells/mL
YPD) were digested with 10 mM phosphate buffer (pH 6.0) containing
1 M sorbitol, lysing enzyme (20 mg/ml), and cellulose (20 mg/ml) for4 h at 28 °C by gentle agitation. The digests were ﬁltered through a
3G3 glass ﬁlter, and protoplasts in the ﬁltrate were gathered by centri-
fugation at 700 ×g for 10 min. The protoplasts were resuspended in
the washing buffer (0.8 M NaCl, 10 mM CaCl2, and 50 mM Tris–HCl,
pH 7.5) and centrifuged again. Bac8c or Melittin was added to the
protoplasts, then suspended in the washing buffer and incubated for 4
h 28 °C. The protoplasts treated with peptides were then transferred
into YPD soft-agar solutions containing 1 M sorbitol and 0.5% agar,
and then spread on agar plates of YPD medium containing 1 M sorbitol
and 2% agar. The regenerated colonies were counted following incuba-
tion of the plates at 28 °C for 3 days [17], and experiments were
performed three independent times.
2.6. Membrane depolarization assay
To analyze membrane disturbances due to Bac8c or melittin treat-
ment, C. albicans cells (1 × 106 cells/mL YPD) were incubated with
Bac8c or melittin at their respective MICs for 4 h at 28 °C; the cells
were then harvested by centrifugation and resuspended in 1 mL PBS
(pH 7.4). Subsequently, the cells were treated with 5 μg of bis-(1,3-
dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] (Molecular
Probes, Eugene, OR, USA) [18]. Flow cytometry analysis was performed
with a FACSCalibur ﬂow cytometer (Becton-Dickinson, Franklin Lakes,
NJ, USA).
C. albicans cells (1 × 106 cells/mL YPD) were washed with Ca2+ and
Mg2+ free PBS, and the collapse of the cytoplasmicmembrane potential
by peptides was observed with DiSC3(5) (Sigma Chemical Co., St. Louis,
MO, USA). Changes in the ﬂuorescence were continuously monitored
with using spectroﬂuorophotometer at an excitation wavelength of
622 nm and an emission wavelength of 670 nm [19]. All experiments
were performed three independent times.
2.7. Propidium iodide inﬂux assay
Fungal membrane permeabilization after treatment with antimicro-
bial peptides was detected using the propidium iodide inﬂux assay.
C. albicans cells (1 × 106 cells/mL YPD) were treated with either Bac8c
ormelittin for 4 h at 28 °C, thenwerewashed in PBS. Cells were harvest-
ed by centrifugation and resuspended in PBS. Subsequently, the cells
were treated with 6 μΜ propidium iodide and incubated for 5 min at
room temperature. The uptake of propidium iodide into C. albicans
cells was analyzed with a FACSCalibur ﬂow cytometer, and the results
are based on three independent experiments, performed in triplicate.
2.8. Preparation of calcein-loaded liposomes and leakage assay
LUVs, composed of phosphatidylcholine/phosphatidylethanolamine/
phosphatidylinositol/ergosterol [PC/PE/PI/ergosterol (5:4:1:2, w/w/
w/w)], were prepared by vortexing dried lipids in a dye buffer solution
(70mMcalcein, 10mMTris, 150mMNaCl, and 0.1mMEDTA [pH 7.4]),
to obtain large unilamellar vesicles (LUVs)which contained calcein. The
suspensionwas freeze-thawed in liquid nitrogen 13 times and extruded
through polycarbonate ﬁlters (Avestin Inc., Ottawa, Canada). Any free
calcein, which had not been entrapped in the LUVs, was removed
using a gelﬁltration process on a Sephadex G-50 column. For the calcein
leakage assay, a suspension of liposomes containing calceinwas treated
with the putative antifungal peptides. The mixture (1 mL ﬁnal volume)
was stirred for 10 min in the dark and centrifuged at 12,000 ×g for
Table 3
Effect of Bac8c on cell wall regeneration of C. albicans
protoplast.
Peptides FRa
Controlb 88.2
Bac8c 4.31
Melittin 3.57
a Frequency of regeneration (FR) values were calcu-
lated by the formula: FR (%) = [(number of colonies
on plate)]/[(number of protoplast used)] × 100.
b Control indicates no compound treatment.
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the ﬂuorescence intensity of the supernatant at 25 °C at an excitation
wavelength of 490 nm and an emission wavelength of 520 nm with a
spectroﬂuorophotometer (Shimadzu, RF-5301 PC; Shimadzu, Kyoto,
Japan). Twenty microliters of 10% Triton X-100 was added to
the vesicles to determine the maximum ﬂuorescence intensity
from 100% calcein leakage. The percentage of calcein leakage
caused by the peptide compounds was calculated as follows:
calcein leakage (%) =100 × (F – F0)/(Ft – F0), where F represents
the ﬂuorescence intensity achieved after addition of the peptides and
F0 and Ft represent the ﬂuorescence intensities without the peptides
and with Triton X-100, respectively [20]. The data represent the
mean ± standard deviation for three independent experiments.
2.9. Preparation of dextran-loaded liposomes and estimation of the
pore size
FITC-labeled dextrans (FD) (FD4, FD10, and FD20) were used to
evaluate the membrane-active mechanism of Bac8c. LUVs containingFig. 1.Membrane damage induced by Bac8c in C. albicans. (A) DiBAC4(3) staining for detection
with Bac8c at theMIC, (c) cells treatedwithmelittin at theMIC. (B)Depolarization of themembr
added at t= 150 s to monitor the changes in ﬂuorescence. (C) Propidium iodide staining for dFD were prepared with the reverse-phase evaporation method [21].
To prepare liposomes containing FD, 1 mL buffer I (50 mM potassium
phosphate, pH 7.4, with 0.1 mM EDTA), containing 2 mg/ml of FD,
was sonicated (JAC 2010; KODO, Korea) for 30 min with 20 mg/mL
of lipid [PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w)] solution in chloroform
on ice. Chloroform was removed using a rotary vacuum evaporator
for 2 h at 25 °C, resulting ﬁrst in the formation of a viscous gel, and
then a liposome suspension. Buffer I (2 mL) was added, and the sus-
pension was evaporated further for the removal of eventual traces of
chloroform. The liposome suspension was sonicated, centrifuged,
and washed for several cycles at 12,000 ×g for 30 min to remove
the free FD. For the assay, a suspension of FD-loaded liposomes was
treated with 10 μM of the peptides. The molar ratio of peptide:lipid
was 1:50. The mixture (1 mL, ﬁnal volume) was stirred for 10 min
in the dark and then centrifuged at 12,000 ×g for 20 min. The super-
natant was recovered, and its ﬂuorescence intensity was recorded
at an excitation wavelength of 494 nm and an emission wavelength
of 520 nm with a spectroﬂuorophotometer. The maximum ﬂuores-
cence intensity was determined by adding 20 μL of 10% Triton
X-100 to the liposome suspension. The percentage of FD leakage
was calculated in the same way as the percentage of calcein leakage,
above. The data represent the mean ± standard deviation for three
independent experiments.
C. albicans cells (1 × 106 cells/mL YPD) were suspended in PBS,
treated with either Bac8c or melittin for 4 h at 28 °C and the
cells were harvested by centrifugation and resuspended in PBS.
Subsequently, the soluble ﬂuorescent molecules FD4, FD10 and
FD20 were added to the C. albicans cells to ﬁnal concentration of
0.1 mg/ml, respectively. The inﬂux of the ﬂuorescent molecules
was observed with a ﬂuorescent microscope (Nikon eclipse Ti-S;
Nikon, Japan) [22].of dissipation of membrane potential in C. albicans. (a) Untreated control, (b) cells treated
ane potentialwas detected byDiSC3(5). DiSC3(5)was added at t=50 s, andpeptideswere
etection of increase of membrane permeability in Bac8c and melittin treated C. albicans.
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The ability peptides to induce pore formationwas estimated bymea-
suring efﬂux of potassium ions from C. albicans using an ion-selective
electrode (ISE) meter (Orion star A214; Thermo Scientiﬁc, Singapore).
C. albicans cells (1 × 106 cells/mL YPD) were treated with either Bac8c
or melittin for 4 h at 28 °C. The incubated cells were centrifuged at
12,000 ×g for 5 min to remove the cell debris. Potassium ion concentra-
tion in the supernatant was expressed as a percentage of the total free
potassium ion, calculated following sonication [23,24].
2.11. Preparation of GUVs
Giant unilamellar vesicles (GUVs) encapsulating calcein were pre-
pared with indium tin oxide (ITO) glasses. Lipids [PC/PE/PI/ergosterol
(5:4:1:2, w/w/w/w)] [25] were prepared at a concentration of
3.75 mg/mL in chloroform. The lipid solutions (200 μL) were spread
onto ITO-coated glass in a spin coater (Spin coater, ACE-1020 Series)
at 700 × g for 5 min. The lipid-coated ITO glass was subjected to evapo-
ration under vacuum for 3 h. The lipid-coated and uncoated glasses
were placed facing each otherwith a 2mm-thick Teﬂon spacer between
them. The chamber was ﬁlled with buffer (10mMHEPES buffer, pH 7.2,
10 μM glucose, 1 mM calcein), and 1.7 V (peak-to-peak, sine wave) and
10Hzof powerwas applied to the ITO electrodes using a sweep function
generator (Protek, SWEEP FUNCTION GENERATOR 9205C) for 2 h. The
voltage across the ITO glass was changed to 4 V (peak-to-peak) at
4 Hz for 10 min. To differentiate the free calcein from GUVs encapsulat-
ing calcein, we used gel ﬁltration chromatography on a Sephadex G-50.
The GUVs were treated with Bac8c or melittin, and the changes in GUV
ﬂuorescence were observed with an inverted ﬂuorescence microscope
[26,27].Fig. 2. (A) Percentage of calcein leakage from the LUVs [PC:PE:PI:ergosterol = 5:4:1:2 (w/w/w
(MIC, 2 × MIC, 3 × MIC and 4 × MIC). (B) Percentage of FITC-dextrans (FDs) leakage induced
liposomes. (C) Observation of ﬂuorescent inﬂux in to viable C. albicans cells under ﬂuorescenc2.12. Three dimensional (3D) ﬂow cytometric contour plot analysis
C. albicans cells (1 × 106 cells/mL YPD) were treated with either
Bac8c or melittin for 4 h at 28 °C. The incubated cells were harvested
by centrifugation and resuspended in PBS. The morphological changes
were analyzed with a FACSCalibur ﬂow cytometer. Non-stained living
cells were evaluated for each sample by excitation with 488 nm light
from an argon ion laser by determining their position on a forward
scatter (FSC) versus side scatter (SSC) contour plot [28].
3. Results and discussion
3.1. Bac8c has an antimicrobial effect with no hemolytic activity
Bactenecin, a 12-mer peptide isolated from bovine neutrophils,
is one of the smallest natural cationic antimicrobial peptides [29].
However, it has been reported that when bactenecin was modiﬁed to
be linearized, the peptide loses its antimicrobial activity [30]. Bac2A
was created by substituting alanine residues for the two cysteine
residues of linearized bactenecin. This modiﬁed peptide has greater
antimicrobial activity than its cyclic or linear forms of bactenecin, with
an additional lower agglutinating activity [30]. Furthermore, many
researchers found that Bac8c, which is an 8-mer peptide derived from
Bac2A, with four favorable amino acid substitutions as determined by
a complete substitution analysis of Bac2A [30,31]. Bac8c not only
showed improved antimicrobial activity against a range of gram-
positive and gram-negative bacteria as well as yeast, but could also be
synthesized rapidly and inexpensively, minimizing its production
costs [11,30,31]. Most previous studies have explored antibacterial ac-
tivity, and although there have been previous reports on the antibacte-
rial mechanisms of Bac8c [31–33], the antifungal effect underlying its/w)] wasmeasured after treatment with the peptides for 10min at various concentrations
by Bac8c and melittin at MIC, respectively, from PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w)
e microscopy.
Fig. 3. Potassium leakage after incubation with MIC value of peptides. The error bars
represent the standard deviation (SD) for three independent experiments.
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mechanism of action of the antimicrobial peptide, Bac8c, in C. albicans.
To determine theMICof Bac8c,we selected pathogenic fungi causing
diverse infectious disease in humans: C. albicans, Candida parapsilosis,
Trichosporon beigelii, and Malassezia furfur. The antimicrobial peptide
melittinwas used as a positive control peptide for comparing the poten-
cy of Bac8c. As shown in Table 1, the fungal strains were susceptible
to Bac8c with a MIC range of 6.3–25.0 μM, and to melittin with a
MIC range of 1.6–6.3 μM. From these results, we determined that
Bac8c shows an inhibitory effect against fungi; we therefore performedFig. 4. (A) The response of a single GUV composed of PC/PE/PI/ergosterol (5:4:1:2,w/w/w/w) in
the time after the addition of the peptides. (B) Three dimensional (3D)-ﬂow cytometric conto
increased FSC values in the 3D density plots relative to the main population of untreated cells
the MIC, (c) cells treated with melittin at the MIC.further experiments to determine the mechanism of inhibition by
Bac8c. Among diverse fungal strains against which the susceptibility
to Bac8c was tested, C. albicans is selected as a model organism for the
experiments in this study because it is the most widespread fungal
pathogen causing candidiasis [34,35].
Furthermore, it is essential that the potential toxic effects of the
Bac8c are tested. To observe hemolytic effect of Bac8c against human
erythrocytes, the release of hemoglobin was estimated. As shown in
Table 2, Bac8c has no hemolytic effect at any concentration whereas
melittin showed 100% of hemolysis at 50 μM. From these result, we
suggests that Bac8c has more activity against fungal cells compared
to human erythrocytes and it can be a candidate for further drug
development.
3.2. Bac8c induces membrane damage in C. albicans
While antifungal agents can target various cellular structures
such as membranes, cell walls, and nuclei, most antifungal agents
have a mechanism of action involving the cell membrane [36].
From the investigation regarding an effect of the Bac8c on the cell
wall regeneration of protoplast of C. albicans, the frequency of regener-
ation (FR) of Bac8c- or melittin-treated protoplasts was extremely low
as compared to the untreated protoplasts (Table 3). This result indicates
that the antifungal activity of peptides is due to the interaction between
the peptides and the plasma membrane, rather than cell wall [17].
Therefore, we investigated the effect of Bac8c on the membranes of
C. albicans to elucidate the antifungal mechanism of Bac8c.
To examine whether Bac8c can affect the function of the fungal
membrane, changes in membrane potential were detected with
the anionic lipophilic dye DiBAC4(3). Increased ﬂuorescence of
DiBAC4(3) indicates membrane depolarization, as DiBAC4(3) exhibits
high voltage-sensitivity and enters depolarized cells, where it binds to
lipid-rich intracellular components [37]. In cells exposed to Bac8c andthe presence of the peptides at 0, 10, 20, 30, 40, and 50 s. The times above each image show
ur-plot analysis of C. albicans. FSC is an indicator of cell size, and peptides at the MIC had
, indicating shrinkage of C. albicans. (a) Untreated control, (b) cells treated with Bac8c at
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68.30%, respectively, compared to untreated cells (Fig. 1A). These
results indicate that Bac8c induces dissipation of the cytoplasmic
membrane potential of C. albicans. We also showed that the correla-
tion between concentrations of Bac8c and degree of membrane de-
polarization using potential sensitive ﬂuorescent probe, DiSC3(5).
After quenching the ﬂuorescence of the DiSC3(5), treatment with
Bac8c (at 150 s) resulted in an increase in the ﬂuorescence intensity
and depolarization correlate with dosage of Bac8c (Fig. 1B).
Furthermore, the effect of Bac8c on the integrity of plasma mem-
branes of C. albicans was examined by propidium iodide inﬂux assay.
Propidium iodide is a membrane-impermeable dye, which only enters
cells through damaged membranes [38,39]. As shown in Fig. 1C, the
ﬂuorescence of C. albicans cells increased by 49.59% when treated with
Bac8c at the MIC compared to the negative control, indicating damage
to the membrane structure. When C. albicans cells were treated with
melittin at the MIC, the cell ﬂuorescence increased by 77.34%. These
data indicate that Bac8c causes membrane damage, which disturbs the
membrane potential and reduces membrane integrity. Although Bac8c
has variant structure, this peptide possesses common characteristics of
antimicrobial peptides such as cationic charge and amphipathicity [40].
Therefore, we assumed that Bac8c interact with fungal cell membrane
with electrostatic and/or hydrophobic interaction, and cause membrane
disruption [41]. Based on the results of membrane depolarization and
propidium iodide assay, we further examined the antifungal activity of
Bac8c on fungal cell membranes.
3.3. Bac8c induces pore formation on the C. albicans membrane
The propidium iodide inﬂux assay can be considered not only
indicative of a loss of membrane integrity, but also of pore formation
in the cell membrane [42]. Therefore, we hypothesized that the
mechanism of action of Bac8c on the cell membrane might be related
to pore formation. To elucidate the mechanism of action, and exam-
ine the extent of membrane damage induced by the peptides, the
leakage of different dyes with various molecular weights from
peptide-treated artiﬁcial liposomes was measured. The dyes used
were calcein (average molecular weight = 623 Da, Stokes-Einstein
radius = 0.74 nm) [43] and the FD4 (average molecular weight =
4 kDa, Stokes-Einstein radius = 1.4 nm), FD10 (average molecular
weight= 10 kDa, Stokes-Einstein radius= 2.3 nm) and FD20 (average
molecular weight = 20 kDa, Stokes-Einstein radius = 3.3 nm) [44].
The artiﬁcial liposomes were LUVs composed of PC/PE/PI/ergosterol
(5:4:1:2, w/w/w/w), resembling the outer leaﬂet of the plasma mem-
brane of C. albicans [45]. Bac8c induced dose-dependent calcein leakage
from LUVs at all the tested concentrations (Fig. 2A). In the FD leakage
assay, melittin induced the release of FD4 and FD10 from LUVs, but
did not induce release of FD20, suggesting the size of the pore formed
by melittin was larger than 2.3 nm. Bac8c also caused the release of
FD4 and FD10 from LUVs, but did not induce release of FD20, indicating
the size of the pore formed by Bac8c treatment was larger than 2.3 nm
(Fig. 2B). This result shows that Bac8c induced the formation of pores
with radii between 2.3 nm and 3.3 nm and it is also supported by the
observation of the ﬂuorescent inﬂux in to viable C. albicans cells using
the ﬂuorescent microscope. As shown in Fig. 2C, the inﬂux of FD4 and
FD10 were detected, but FD20 did not enter the cytoplasm of the cells
after the addition of Bac8c. Taken together, these results showed that
Bac8c induced pore formation and increased the permeability of
the fungal membrane. Hence, the fungal cells experienced membrane
depolarization, which causes a loss of ions, due to Bac8c treatment
eventually leading to fungal cell shrinkage and cell death.
3.4. Leakage of intracellular potassium ions
To further validate membrane pore formation in case of Bac8c-
treated C. albicans, potassium release was measured using a potassium-sensitive electrode. Potassium efﬂux induced by Bac8c was less efﬁcient
than that induced by melittin. In untreated C. albicans cells, 14.8% of the
potassium ions were released from the cells, while Bac8c-treated cells
showed a 42.4% release of potassium ions. In comparison, melittin-
treated C. albicans showed a 66.7% release of potassium ions (Fig. 3).
This result suggests that Bac8c induced leakage of intracellular
components, especially potassium ions, from C. albicans.
Cellular homeostasis is central to life and in microbial pathogens is
attained by controlling the permeability of the cytoplasmic membrane
to ions and solutes. The potassium ion gradient is an important determi-
nant of growth and survival through its role in regulating cytoplasmic
pH and cell structure [46]. Therefore, a loss of cytoplasmic potassium
would lead to cell death in fungi [47]. Leakage of potassium ions
can be evaluated to determine membrane-lytic events in fungi and
liposomes, since the internal ionic environment in cells is usually
potassium-rich [48]. The loss of the potassium gradient across the
cell membrane is an outcome of membrane damage, and can lead to
compromise of membrane functions and, eventually, cell death.3.5. Visualization of the fungal membrane-disruptive action of Bac8c
Positively-charged antimicrobial peptides can accumulate on the
anionic microbial cell surface containing acidic polymers and contact
cytoplasmic membrane [49]. Membrane permeabilization and depolar-
ization by antimicrobial peptides causes disruption of the lipid bilayer,
inducing the formation of micelles, transmembrane pores, and toroidal
pores [50,51]. To understand the membrane-active mechanisms
more accurately, we used GUVs containing calcein. GUVs, composed
of PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w) [52] and mimicking the
membranes of C. albicans, were prepared using the electroformation
method [45]. GUVs have become a useful model for imitating biological
membranes [53]. Morphological changes in the artiﬁcial model mem-
brane allow the study of structural and physical changes during interac-
tions with antimicrobial agents [43,54]. Changes in ﬂuorescence are
attributed to structural perturbation of the model membrane after
interaction with antimicrobial peptides [55]. Using ﬂuorescence mi-
croscopy, we observed changes in ﬂuorescence of the GUVs in response
to treatment with peptides. When treated with Bac8c or melittin, the
ﬂuorescence of the GUVs was remarkably diminished. This phenome-
non demonstrated that the ﬂuorescent calcein probe escaped through
peptide-induced pores on the liposome. In addition, the untreated
GUVs showed no changes in the ﬂuorescence intensity (Fig. 4A).
Morphological changes in the cells were also characterized using
ﬂow cytometry to compare the FSC and SSC proﬁles of Bac8c-treated
cells. In general, FSC is an indicator of cell size and SSC is an indicator
of granularity. Fig. 4B shows that the cells treated with Bac8c and
melittin had decreased FSC values in the 3D density plots relative
to the main population of untreated cells, indicating shrinkage of
C. albicans. The cell shrinkages demonstrated that membrane perme-
ability increased by pore and cell shrinkage occurred along with the
loss of ions or intracellular components [56]. These results clearly
suggest that the membrane-targeted mechanism of Bac8c lies in
pore formation within the fungal membrane.
In conclusion, Bac8c exhibited potent antifungal effect on various
fungal strains via membrane disruption mechanisms involving pore
formation. Therefore, we suggest that as Bac8c is considered a potential
candidate to develop into a novel antimicrobial agent because of its high
antimicrobial activity without cytotoxicity and low production costs.Acknowledgement
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